12,853 resources
Start Prev Rows 8400 - 8600 Next
| Package | Version | Identity | Name/Title | Status | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter | active | 2024-10 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.189 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia | active | 2024-10 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy | active | 2024-10 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.192 | Spontaneous or Elective Abortion Procedure | active | 2025-01 | hl7 | cms |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension | active | 2024-10 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy | active | 2024-10 | hl7 | vsac |
| hl7.fhir.us.davinci-pct | R4 | PCTGFEItemRevenueVS | PCT GFE NUBC Revenue Value Set | active | 2025-06 | hl7 | |
| hl7.fhir.us.davinci-pct | R4 | PCTGFETypeOfBillVS | PCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Set | active | 2025-06 | hl7 | |
| signal.core.r4 | R4 | provider-taxonomy | Provider Taxonomy Codes | draft | 2023-03 | hl7 | nucc |
| fhir.cdc.opioid-cds-r4 | R4 | oncology-specialty-designations | Oncology specialty designations (NUCC) | active | 2023-05 | hl7 | nucc |
| hl7.fhir.us.vdor | R4 | vdor-gun-owner-codes-vs | VDOR Coding Manual Gun Owner Codes Value Set | draft | 2025-06 | hl7 | fhir sct |
| hl7.fhir.us.registry-protocols | R4 | NewYorkHeartAssociationAnswers | New York Heart Association OA Answer List | active | 2023-11 | hl7 | loinc |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex | active | 2025-02 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3043 | Lab Test Result Name (Hepatitis) | active | 2008-01 | loinc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7954 | Medication Administered (Hansen) | active | 2020-01 | rx tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) | active | 2020-01 | sct rx tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7721 | Cruise Line (RIBD) | active | 2018-01 | tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) | active | 2020-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7952 | Tribe Name (NND) | active | 2020-01 | tho oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.292 | Non pharmacologic treatments for chronic pain NCI | active | 2024-06 | hl7 | ncit |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3279 | H1N1 Vaccine Manufacturer | active | 2009-01 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3236 | National Reporting Jurisdiction | active | 2009-01 | oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.581 | PIM_Avandamet | active | 2023-08 | hl7 | rx |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.26 | Nonopioid pain medications | active | 2023-03 | hl7 | rx |
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.59 | DIRSectionTypeCodes | active | 2024-06 | hl7 | vsac |
| fhir.org.nz.ig.base | R4 | coverage-type | Coverage Type | active | 2025-06 | hl7 | |
| fhir.org.nz.ig.base | R4 | coverage-category | Coverage Category | active | 2025-06 | hl7 | |
| fhir.org.nz.ig.base | R4 | iwi | Iwi | active | 2025-06 | hl7 | |
| hl7.fhir.us.hsds | R4 | NonIndividualSpecialties | Non-Individual Specialties | active | 2023-10 | hl7 | nucc |
| hl7.fhir.us.directory-query | R4 | NonIndividualSpecialtiesVS | Non-Individual Specialties | active | 2022-12 | hl7 | nucc |
| hl7.fhir.us.davinci-pdex-plan-net | R4 | NonIndividualSpecialtiesVS | Non-Individual Specialties | active | 2025-02 | hl7 | nucc |
| hl7.fhir.us.directory-query | R4 | NonIndividualSpecialtyAndDegreeLicenseCertificateVS | Non-Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | hl7 | fhir tho |
| hl7.fhir.us.davinci-pdex-plan-net | R4 | NonIndividualSpecialtyAndDegreeLicenseCertificateVS | Non-Individual Specialties, Degrees, Licenses, and Certificates VS | active | 2025-02 | hl7 | fhir tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.279 | Triage | active | 2025-02 | hl7 | sct |
| hl7.fhir.us.registry-protocols | R4 | NonSustainedVentricularTachycardiaType | Non-Sustained Ventricular Tachycardia Type | active | 2023-11 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7279 | Non-Treponemal Test Result (STD) | active | 2017-01 | tho oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.114 | NSAIDs Ingredients and Risk of GI Bleeding | active | 2023-12 | hl7 | rx |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) | active | 2014-01 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-normalization-basis-vs | Normalization Basis Value Set | active | 2025-02 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers | active | 2024-12 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions | active | 2024-12 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions | active | 2024-12 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments | active | 2023-12 | hl7 | loinc |
| hl7.fhir.us.breast-radiology | R4 | NotPreviouslySeenVS | NotPreviouslySeen ValueSet | active | 2022-12 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine | active | 2023-07 | hl7 | loinc |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.898 | Forearm X Ray | active | 2024-07 | hl7 | loinc |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.455 | Metabolic acidosis I10 | active | 2023-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences | active | 2025-04 | hl7 | loinc |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) | active | 2008-01 | sct oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1031 | Public Health Case Record Type | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8058 | Nucleic Acid Viral Load Test Result (Hepatitis) | active | 2021-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) | active | 2008-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) | active | 2008-01 | sct tho oid | |
| hl7.fhir.us.davinci-crd | R4 | cmslocationcodes | CMS Location Codes Value Set | active | 2025-07 | hl7 | fhir |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain | active | 2015-08 | hl7 | sct |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 | selected muscle relaxants for pain control | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 | Selected topical agents for pain control | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 | selected non opioids for moderate to severe pain | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 | Selected opioids for moderate to severe pain | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete | active | 2015-08 | hl7 | loinc |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy | active | 2015-08 | hl7 | loinc |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.999.3.1 | Opioids used for pain control | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 | selected first line medications for pain control | active | 2015-08 | hl7 | rx |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring | active | 2015-08 | hl7 | sct |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1019 | Diseases of Urinary System | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1301 | Surgery Integumentary System Breast | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1302 | Surgery Respiratory System Accessory Sinuses | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1303 | Surgery Respiratory System Larynx | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1304 | Surgery Respiratory System Trachea and Bronchi | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1305 | Surgery Respiratory System Lungs and Pleura | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13064 | Surgery Digestive System Esophagus | active | 2020-06 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1307 | Surgery Digestive System Intestines (Except Rectum) | active | 2017-05 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1308 | Surgery Digestive System Rectum | active | 2019-08 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1309 | Surgery Digestive System Anus | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1310 | Surgery Digestive System Biliary Tract | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1311 | Surgery Digestive System Abdomen Peritoneum Omentum | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1312 | Surgery Digestive System Kidney | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13133 | Surgery Digestive System Ureter | active | 2017-05 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1314 | Surgery Digestive System Bladder | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1315 | Surgery Female Genital System Cervix Uteri | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1316 | Surgery Female Genital System Corpus Uteri | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1317 | Surgery Female Genital System Oviduct Ovary | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1318 | Surgery Eye and Ocular Adnexa Anterior Segment | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13193 | Other Surgeries | active | 2017-05 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13202 | SPECT MPI | active | 2020-06 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13213 | Stress Echocardiography | active | 2017-05 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.13222 | Stress MRI | active | 2020-06 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1323 | CCTA | active | 2020-07 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1329 | Diabetes Mellitus | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1330 | Renal insufficiency | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1331 | Stroke transient ischemic attack | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1332 | Prior heart failure | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1333 | Ischemic heart disease | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1804 | Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRI | active | 2020-08 | hl7 | cpt |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.18143 | Patients with lumbar spine surgery in the 90 days prior to MRI | active | 2020-08 | hl7 | vsac |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1832 | Cancer | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1838 | Neoplastic abnormalities | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1839 | Treatment fields for radiation therapy | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1842 | Postoperative fluid collections and soft tissue changes | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1847 | Unspecified Immune Deficiencies | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1833 | Congenital spine and spinal cord malformations | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1834 | Inflammatory and autoimmune disorders | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1835 | Infectious conditions | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1836 | Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhage | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1837 | Spinal cord infarction | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1840 | Spinal abnormalities associated with scoliosis | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1841 | Syringohydromyelia | active | 2020-08 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1844 | IV Drug Abuse | active | 2022-04 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1845 | Neurological Impairment | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1846 | Human Immunodeficiency Virus | active | 2020-07 | hl7 | icd |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1843 | Trauma | active | 2020-07 | hl7 | icd |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1069 | Material | active | 2010-01 | sct | |
| signal.core.r4 | R4 | observation-category | Observation Category Codes | draft | 2019-10 | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3357 | Observation Result Handling (HL7) | active | 2010-01 | tho | |
| hl7.fhir.us.vdor | R4 | vdor-toxicology-summary-tests-vs | VDOR Toxicology Summary Tests Value Set | draft | 2025-06 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.78 | Observation Interpretation (HL7) | active | 2009-01 | tho | |
| hl7.fhir.us.breast-radiology | R4 | ObservedChangesVS | ObservedChanges ValueSet | active | 2022-12 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.887 | Occupation | active | 2008-01 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) | active | 2008-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1044 | Specimen Reject Reason (HL7) | active | 2008-01 | tho | |
| fhir.cdc.opioid-cds-r4 | R4 | synthetic-opioid-medications | Synthetic opioid medications | active | 2023-05 | hl7 | |
| hl7.fhir.us.carin-bb | R4 | OralBodySite | Oral Body Site Value Set | active | 2025-02 | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.923 | Order Control Code (HL7) | active | 2008-01 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1027 | Previous Vaccine History | active | 2008-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7740 | Colony Count Magnitude | active | 2018-01 | tho oid | |
| hl7.fhir.us.hai | R4 | nhsn-pathogen-ranking | NHSNPathogenRanking | active | 2023-09 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7617 | Organism (FDD) | active | 2020-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) | active | 2019-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) | active | 2009-01 | sct tho oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List | active | 2024-01 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3062 | Transplant Organ | active | 2010-01 | sct | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.8 | Vaccine Clinical Drug | active | 2024-06 | hl7 | rx |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) | active | 2016-01 | sct oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) | active | 2008-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3094 | Other Related Cases | active | 2008-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8050 | Other Case Hepatitides (Hepatitis) | active | 2021-01 | sct oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) | active | 2008-01 | sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) | active | 2008-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) | active | 2018-01 | sct tho | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.86 | Pregnancy Outcome | active | 2024-06 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) | active | 2018-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) | active | 2020-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) | active | 2010-01 | sct tho oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4436 | Gentamicin medications | active | 2024-05 | hl7 | rx |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3294 | PHIN Questions (CRS) | active | 2010-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3295 | PHIN Questions (Malaria) | active | 2010-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3298 | PHIN Questions (Rubella) | active | 2010-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3299 | PHIN Questions (Strep Pneumo) | active | 2010-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3050 | PHIN Questions (Animal Rabies) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3051 | PHIN Questions (ArboNet) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3052 | PHIN Questions (FDD) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3277 | PHIN Questions (Flu) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3276 | PHIN Questions (Flu Summary) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3053 | PHIN Questions (Generic) | active | 2011-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1063 | PHIN Questions (Lead Case) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1065 | PHIN Questions (Lead Environmental) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1064 | PHIN Questions (Lead Laboratory Report) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3238 | PHIN Questions (Measles) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3237 | PHIN Questions (Mumps) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3278 | PHIN Questions (Pediatric Flu) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3239 | PHIN Questions (Summary) | active | 2009-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1061 | PHIN Questions (TB) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3054 | PHIN Questions (VPD) | active | 2008-01 | oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1062 | PHIN Questions (Varicella) | active | 2008-01 | oid | |
| hl7.fhir.us.registry-protocols | R4 | PCIOperator | PCI Operator SNOMED codes | active | 2023-11 | hl7 | sct |
| ca.on.dhdr.r4.v4 | R4 | encounter-participant-type | Encounter Participant Type | active | 2019-02 | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) | active | 2020-01 | sct | |
| hl7.fhir.us.registry-protocols | R4 | PatientCenteredReasonforDelay | Patient Centered Reason for Delay | active | 2023-11 | hl7 | fhir |
| fhir.kenyaPSIG | R4 | PatientContactRlshipVS | Patient Contact Relationship ValueSet | draft | 2025-07 | hl7 | internal |
| fhir.kenyaPSIG | R4 | PatientIdentifierTypesVS | Patient Identifier Types ValueSet | draft | 2025-07 | hl7 | internal |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3404 | Patient Class (Syndromic Surveillance) | active | 2015-01 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) | active | 2022-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) | active | 2022-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) | active | 2022-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) | active | 2022-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.756 | Gender Identity | active | 2021-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7610 | Gender Identity (STD) | active | 2017-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) | active | 2022-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7563 | Sexual Orientation | active | 2017-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) | active | 2018-01 | sct tho | |
| fhir.kenyaPSIG | R4 | PatientTitleVS | Patient title | draft | 2025-07 | hl7 | internal |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status | active | 2008-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7713 | College Living Situation (RIBD) | active | 2018-01 | tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) | active | 2019-01 | cdc sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.994 | General Condition Status | active | 2008-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3163 | Immigration Status | active | 2008-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3018 | Patient Location Status at Specimen Collection | active | 2008-01 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7779 | Condition Status (FDD) | active | 2020-01 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) | active | 2018-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) | active | 2018-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) | active | 2020-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) | active | 2019-01 | sct tho oid | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) | active | 2008-01 | sct tho oid | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.66 | PCI | active | 2017-05 | hl7 | cms |
| hl7.fhir.us.military-service | R4 | military-service-paygrade-vs | Pay Grade Code Value Set | active | 2023-05 | hl7 | fhir |
| hl7.fhir.us.ndh | R4 | NdhDirectTrustPayloadTypeVS | NDH Direct Trust Payload Type Value Set | active | 2025-07 | hl7 | fhir ihe tho |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.18 | Medication Drug Class | active | 2024-06 | hl7 | fhir |
FHIR